The annual meeting of the American Academy of Neurology was held this year from April 5 to 9 in San Diego. Participants ...

A STAT investigation last year revealed that UnitedHealth Group, which owns the country’s largest Medicare Advantage insurer, ...

For the first time in 30 years, a new drug class known as the CGRP-Antagonists (calcitonin gene-related peptide) has emerged.

Click Therapeutics has collected a groundbreaking green light from the FDA for the agency’s first prescription digital ...

Drugs have been the standard migraine treatment for decades. The severe headaches, nausea, and other problems associated with this common disorder now have a digital treatment option, a mobile app ...

The software-based intervention aims to reduce brain hypersensitivity in patients with migraine by modulating responses to environmental and internal stimuli through a 12-week program.

The following is a summary of “A National Cross-Sectional Survey on Real-World Experiences of Calcitonin Gene-Related Peptide ...

Adults with dry eye disease and migraine who were treated with eye drops for ocular lubrication experienced significant reductions in migraine severity, according to a study published in Optometry and ...

Despite the availability of preventive migraine medications, many patients continue to experience frequent and debilitating attacks, which can negatively impact key aspects of life such as employment, ...

The FDA has granted marketing authorization to CT-132, an adjunctive, prescription digital therapeutic for the preventive treatment of episodic migraine.